'en:growth factors, combined defect of'
(id=8559672 ; fe=en:growth factors, combined defect of ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=1114 creation date=2017-07-31 touchdate=2025-09-04 16:42:35.000) ≈ 35 relations sortantes
- en:growth factors, combined defect of --
r_associated #0: 42 / 1 ->
en:membranous lipodystrophy
n1=en:growth factors, combined defect of | n2=en:membranous lipodystrophy | rel=r_associated | relid=0 | w=42
- en:growth factors, combined defect of --
r_associated #0: 38 / 0.905 ->
en:familial partial lipodystrophy
n1=en:growth factors, combined defect of | n2=en:familial partial lipodystrophy | rel=r_associated | relid=0 | w=38
- en:growth factors, combined defect of --
r_associated #0: 35 / 0.833 ->
en:insulin
n1=en:growth factors, combined defect of | n2=en:insulin | rel=r_associated | relid=0 | w=35
- en:growth factors, combined defect of --
r_associated #0: 34 / 0.81 ->
en:aredyld syndrome
n1=en:growth factors, combined defect of | n2=en:aredyld syndrome | rel=r_associated | relid=0 | w=34
- en:growth factors, combined defect of --
r_associated #0: 34 / 0.81 ->
en:epidermal growth factor
n1=en:growth factors, combined defect of | n2=en:epidermal growth factor | rel=r_associated | relid=0 | w=34
- en:growth factors, combined defect of --
r_associated #0: 34 / 0.81 ->
en:insulin-like growth factor i
n1=en:growth factors, combined defect of | n2=en:insulin-like growth factor i | rel=r_associated | relid=0 | w=34
- en:growth factors, combined defect of --
r_associated #0: 34 / 0.81 ->
en:lipoatrophic diabetes mellitus
n1=en:growth factors, combined defect of | n2=en:lipoatrophic diabetes mellitus | rel=r_associated | relid=0 | w=34
- en:growth factors, combined defect of --
r_associated #0: 34 / 0.81 ->
en:partial lipodystrophy
n1=en:growth factors, combined defect of | n2=en:partial lipodystrophy | rel=r_associated | relid=0 | w=34
- en:growth factors, combined defect of --
r_associated #0: 32 / 0.762 ->
en:facial wasting
n1=en:growth factors, combined defect of | n2=en:facial wasting | rel=r_associated | relid=0 | w=32
- en:growth factors, combined defect of --
r_associated #0: 32 / 0.762 ->
en:lipoatrophy
n1=en:growth factors, combined defect of | n2=en:lipoatrophy | rel=r_associated | relid=0 | w=32
- en:growth factors, combined defect of --
r_associated #0: 32 / 0.762 ->
en:lipodystrophy caused by antiretroviral drug
n1=en:growth factors, combined defect of | n2=en:lipodystrophy caused by antiretroviral drug | rel=r_associated | relid=0 | w=32
- en:growth factors, combined defect of --
r_associated #0: 32 / 0.762 ->
en:partial face-sparing lipodystrophy
n1=en:growth factors, combined defect of | n2=en:partial face-sparing lipodystrophy | rel=r_associated | relid=0 | w=32
- en:growth factors, combined defect of --
r_associated #0: 31 / 0.738 ->
en:acquired generalized lipodystrophy
n1=en:growth factors, combined defect of | n2=en:acquired generalized lipodystrophy | rel=r_associated | relid=0 | w=31
- en:growth factors, combined defect of --
r_associated #0: 31 / 0.738 ->
en:autoinflammation, lipodystrophy and dermatosis syndrome
n1=en:growth factors, combined defect of | n2=en:autoinflammation, lipodystrophy and dermatosis syndrome | rel=r_associated | relid=0 | w=31
- en:growth factors, combined defect of --
r_associated #0: 31 / 0.738 ->
en:generalized lipodystrophy
n1=en:growth factors, combined defect of | n2=en:generalized lipodystrophy | rel=r_associated | relid=0 | w=31
- en:growth factors, combined defect of --
r_associated #0: 31 / 0.738 ->
en:lipodystrophy acquired
n1=en:growth factors, combined defect of | n2=en:lipodystrophy acquired | rel=r_associated | relid=0 | w=31
- en:growth factors, combined defect of --
r_associated #0: 31 / 0.738 ->
en:lipohypertrophy
n1=en:growth factors, combined defect of | n2=en:lipohypertrophy | rel=r_associated | relid=0 | w=31
- en:growth factors, combined defect of --
r_associated #0: 30 / 0.714 ->
en:dystrophy
n1=en:growth factors, combined defect of | n2=en:dystrophy | rel=r_associated | relid=0 | w=30
- en:growth factors, combined defect of --
r_associated #0: 28 / 0.667 ->
en:focal lipodystrophy
n1=en:growth factors, combined defect of | n2=en:focal lipodystrophy | rel=r_associated | relid=0 | w=28
- en:growth factors, combined defect of --
r_associated #0: 28 / 0.667 ->
en:hiv-associated lipodystrophy syndrome
n1=en:growth factors, combined defect of | n2=en:hiv-associated lipodystrophy syndrome | rel=r_associated | relid=0 | w=28
- en:growth factors, combined defect of --
r_associated #0: 28 / 0.667 ->
en:lipodystrophy of face
n1=en:growth factors, combined defect of | n2=en:lipodystrophy of face | rel=r_associated | relid=0 | w=28
- en:growth factors, combined defect of --
r_associated #0: 28 / 0.667 ->
en:sclerema
n1=en:growth factors, combined defect of | n2=en:sclerema | rel=r_associated | relid=0 | w=28
- en:growth factors, combined defect of --
r_associated #0: 27 / 0.643 ->
en:deficiency aspects
n1=en:growth factors, combined defect of | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=27
- en:growth factors, combined defect of --
r_associated #0: 27 / 0.643 ->
en:familial generalized lipodystrophy
n1=en:growth factors, combined defect of | n2=en:familial generalized lipodystrophy | rel=r_associated | relid=0 | w=27
- en:growth factors, combined defect of --
r_associated #0: 27 / 0.643 ->
en:progressive hemifacial atrophy
n1=en:growth factors, combined defect of | n2=en:progressive hemifacial atrophy | rel=r_associated | relid=0 | w=27
- en:growth factors, combined defect of --
r_associated #0: 26 / 0.619 ->
en:acquired partial lipodystrophy
n1=en:growth factors, combined defect of | n2=en:acquired partial lipodystrophy | rel=r_associated | relid=0 | w=26
- en:growth factors, combined defect of --
r_associated #0: 26 / 0.619 ->
en:hiv lipodystrophy
n1=en:growth factors, combined defect of | n2=en:hiv lipodystrophy | rel=r_associated | relid=0 | w=26
- en:growth factors, combined defect of --
r_associated #0: 26 / 0.619 ->
en:inborn errors of metabolism
n1=en:growth factors, combined defect of | n2=en:inborn errors of metabolism | rel=r_associated | relid=0 | w=26
- en:growth factors, combined defect of --
r_associated #0: 20 / 0.476 ->
en:congenital metabolic disorder
n1=en:growth factors, combined defect of | n2=en:congenital metabolic disorder | rel=r_associated | relid=0 | w=20
- en:growth factors, combined defect of --
r_associated #0: 20 / 0.476 ->
en:genetic lipodystrophy
n1=en:growth factors, combined defect of | n2=en:genetic lipodystrophy | rel=r_associated | relid=0 | w=20
- en:growth factors, combined defect of --
r_associated #0: 20 / 0.476 ->
en:insulin, regular
n1=en:growth factors, combined defect of | n2=en:insulin, regular | rel=r_associated | relid=0 | w=20
- en:growth factors, combined defect of --
r_associated #0: 20 / 0.476 ->
en:regular insulin
n1=en:growth factors, combined defect of | n2=en:regular insulin | rel=r_associated | relid=0 | w=20
- en:growth factors, combined defect of --
r_associated #0: 20 / 0.476 ->
insuline normale
n1=en:growth factors, combined defect of | n2=insuline normale | rel=r_associated | relid=0 | w=20
- en:growth factors, combined defect of --
r_associated #0: 20 / 0.476 ->
insuline ordinaire
n1=en:growth factors, combined defect of | n2=insuline ordinaire | rel=r_associated | relid=0 | w=20
- en:growth factors, combined defect of --
r_associated #0: 3 / 0.071 ->
en:disease or syndrome
n1=en:growth factors, combined defect of | n2=en:disease or syndrome | rel=r_associated | relid=0 | w=3
| ≈ 41 relations entrantes
- insuline ordinaire ---
r_associated #0: 100 -->
en:growth factors, combined defect of
n1=insuline ordinaire | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=100
- en:insulin, regular ---
r_associated #0: 98 -->
en:growth factors, combined defect of
n1=en:insulin, regular | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=98
- en:regular insulin ---
r_associated #0: 90 -->
en:growth factors, combined defect of
n1=en:regular insulin | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=90
- insuline normale ---
r_associated #0: 80 -->
en:growth factors, combined defect of
n1=insuline normale | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=80
- en:deficiency aspects ---
r_associated #0: 35 -->
en:growth factors, combined defect of
n1=en:deficiency aspects | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=35
- en:generalized lipodystrophy ---
r_associated #0: 34 -->
en:growth factors, combined defect of
n1=en:generalized lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=34
- en:genetic lipodystrophy ---
r_associated #0: 31 -->
en:growth factors, combined defect of
n1=en:genetic lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=31
- en:congenital metabolic disorder ---
r_associated #0: 27 -->
en:growth factors, combined defect of
n1=en:congenital metabolic disorder | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=27
- en:inborn errors of metabolism ---
r_associated #0: 21 -->
en:growth factors, combined defect of
n1=en:inborn errors of metabolism | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=21
- en:acquired generalized lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:acquired generalized lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:acquired partial lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:acquired partial lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:aredyld syndrome ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:aredyld syndrome | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:autoinflammation, lipodystrophy and dermatosis syndrome ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:autoinflammation, lipodystrophy and dermatosis syndrome | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:dystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:dystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:epidermal growth factor ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:epidermal growth factor | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:facial wasting ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:facial wasting | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:familial generalized lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:familial generalized lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:familial partial lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:familial partial lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:focal lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:focal lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:hiv lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:hiv lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:hiv-associated lipodystrophy syndrome ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:hiv-associated lipodystrophy syndrome | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:insulin ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:insulin | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:insulin-like growth factor i ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:insulin-like growth factor i | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:lipoatrophic diabetes mellitus ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:lipoatrophic diabetes mellitus | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:lipoatrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:lipoatrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:lipodystrophy acquired ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:lipodystrophy acquired | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:lipodystrophy caused by antiretroviral drug ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:lipodystrophy caused by antiretroviral drug | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:lipodystrophy of face ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:lipodystrophy of face | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:lipohypertrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:lipohypertrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:membranous lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:membranous lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:partial face-sparing lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:partial face-sparing lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:partial lipodystrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:partial lipodystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:progressive hemifacial atrophy ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:progressive hemifacial atrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- en:sclerema ---
r_associated #0: 20 -->
en:growth factors, combined defect of
n1=en:sclerema | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=20
- dystrophy ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=dystrophy | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
- epidermal growth factor ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=epidermal growth factor | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
- insulin ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=insulin | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
- insuline ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=insuline | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
- lipo-atrophie ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=lipo-atrophie | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
- lipoatrophie ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=lipoatrophie | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
- lipohypertrophie ---
r_associated #0: 10 -->
en:growth factors, combined defect of
n1=lipohypertrophie | n2=en:growth factors, combined defect of | rel=r_associated | relid=0 | w=10
|